IFPMA, with support and representation from industry leaders, joins stakeholders this week at the 11th Business Ethics for APEC SMEs Forum. This Forum – and the initiative on which it is based – supports the advancement of ethical business practices in the Asia-Pacific economies, with a focus on the health sector and wider health ecosystem....
Read moreOn 14-15 May 2024, IFPMA was represented at a targeted interdisciplinary discussion within the scope of the WMA Declaration of Helsinki revision. The aim of the meeting was to foster discussion with experts on the paragraphs in the Declaration of Helsinki focused on vulnerable people in research, with a view to contribute the findings to...
Read moreOn 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent.
Read more